These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 26368787

  • 1. Assessing the economic value of avoiding hospital admissions by shifting the management of gram+ acute bacterial skin and skin-structure infections to an outpatient care setting.
    Ektare V, Khachatryan A, Xue M, Dunne M, Johnson K, Stephens J.
    J Med Econ; 2015; 18(12):1092-101. PubMed ID: 26368787
    [Abstract] [Full Text] [Related]

  • 2. Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis.
    Jensen IS, Wu E, Fan W, Lodise TP, Nicolau DP, Dufour S, Cyr PL, Sulham KA.
    J Manag Care Spec Pharm; 2016 Jun; 22(6):752-64. PubMed ID: 27231802
    [Abstract] [Full Text] [Related]

  • 3. Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis.
    Jensen IS, Lodise TP, Fan W, Wu C, Cyr PL, Nicolau DP, DuFour S, Sulham KA.
    Clin Drug Investig; 2016 Feb; 36(2):157-68. PubMed ID: 26692006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States.
    Keyloun KR, Weber DJ, Gardstein BM, Berger A, Gillard P, Ganz ML.
    Hosp Pract (1995); 2018 Dec; 46(5):278-286. PubMed ID: 30067108
    [Abstract] [Full Text] [Related]

  • 6. A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
    McCollum M, Sorensen SV, Liu LZ.
    Clin Ther; 2007 Mar; 29(3):469-77. PubMed ID: 17577468
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S.
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [Abstract] [Full Text] [Related]

  • 8. Transitions of care in the management of acute bacterial skin and skin structure infections: a paradigm shift.
    Verastegui JE, Hamada Y, Nicolau DP.
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1039-45. PubMed ID: 27248789
    [Abstract] [Full Text] [Related]

  • 9. Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
    Revankar N, Ward AJ, Pelligra CG, Kongnakorn T, Fan W, LaPensee KT.
    J Med Econ; 2014 Oct; 17(10):730-40. PubMed ID: 25019580
    [Abstract] [Full Text] [Related]

  • 10. Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.
    Ostermann H, Blasi F, Medina J, Pascual E, McBride K, Garau J, REACH study group.
    J Med Econ; 2014 Oct; 17(10):719-29. PubMed ID: 24983206
    [Abstract] [Full Text] [Related]

  • 11. Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment.
    Lane S, Johnston K, Sulham KA, Syed I, Pollack CV, Holland T, Nathwani D.
    Clin Ther; 2016 Mar; 38(3):531-44; quiz 544.e1-9. PubMed ID: 26874786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections.
    Turco NJ, Kane-Gill SL, Hernandez I, Oleksiuk LM, D'Amico F, Pickering AJ.
    Expert Opin Pharmacother; 2018 Mar; 19(4):319-325. PubMed ID: 29509504
    [Abstract] [Full Text] [Related]

  • 16. Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study.
    Lipsky BA, Napolitano LM, Moran GJ, Vo L, Nicholson S, Chen S, Boulanger L, Kim M.
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):266-72. PubMed ID: 24657171
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
    Bounthavong M, Hsu DI.
    Expert Rev Pharmacoecon Outcomes Res; 2012 Dec; 12(6):683-98. PubMed ID: 23252352
    [Abstract] [Full Text] [Related]

  • 18. Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections.
    LaPensee K, Mistry R, Lodise T.
    Am Health Drug Benefits; 2019 Feb; 12(1-Supplement 2):S13-S24. PubMed ID: 30996767
    [Abstract] [Full Text] [Related]

  • 19. Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings.
    LoVecchio F, McCarthy MW, Ye X, Henry AD, Doan QV, Lock JL, Riccobene T, Lyles RD, Talan DA.
    J Emerg Med; 2024 Aug; 67(2):e217-e229. PubMed ID: 38825531
    [Abstract] [Full Text] [Related]

  • 20. Modeling operational quality metrics and costs of long-acting antibiotics for acute bacterial skin and skin structure infection treatment in the emergency department.
    Keyloun KR, Lofgren E, Hebert S.
    J Med Econ; 2019 Jul; 22(7):652-661. PubMed ID: 30838908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.